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INTRODUCTION
Since 1974, when Sydney Brenner first
introduced Caenorhabditis elegans in the
scientific community as a model organ-
ism (Brenner, 1974), the nematode has
been extensively used as a model sys-
tem to study cellular biology. One of the
most intriguing fields of molecular biol-
ogy that have been investigated using this
model host and that led to the 2002 Nobel
Prize in Physiology or Medicine, is pro-
grammed cell death. Apoptosis is an evo-
lutionarily conservedmethod employed by
multicellular organisms to maintain tissue
homeostasis during development and dif-
ferentiation (Kuranaga, 2011), but can also
serve as a way to prevent growth of cells
mutated due to DNA damage (Bailly and
Gartner, 2013).
THE MAIN APOPTOTIC PATHWAY
In C. elegans, apoptosis is a normal com-
ponent of growth. During development
1090 somatic cells are generated for each
hermaphrodite, of which 131 invariantly
undergo apoptosis (Sulston and Horvitz,
1977; Sulston et al., 1983). Interestingly,
the main effectors of apoptosis in the
worm are conserved inmammalian organ-
isms. Indeed, the main apoptotic pathway
in the nematode starts with the activation
of EGL-1 in the cells that are destined to
die. EGL-1 is a BH3 only protein which,
when activated, binds to and inhibits
CED-9, the only BCL-2-like protein in
C. elegans, and thus negates its inhibiting
effect on CED-4. CED-4 is the analog of
mammalian APAF-1 and it serves as an
activator of CED-3, a caspase, which then
leads to cell death (Gartner et al., 2008).
Under-expression or mutation of effec-
tors within the apoptotic pathway that are
conserved in this model host has been
known to lead to uncontrolled cellular
proliferation and cancer in mammalian
organisms. Indeed, bcl-2 mutations are
found in a wide range of human cancers
(Ciardiello and Tortora, 2002). In support
of this notion, a recent article reported
an alternative mechanism of programmed
cell-death activation on the nematode that
involves inactivation of CED-9 by DRE-
1. DRE-1 is the worm analog of the
human protein FBXO10, which is known
to be mutated or expressed at low levels
in human diffuse large B-cell lymphomas
(Chiorazzi et al., 2013).
Meanwhile, apoptosis seems to play an
active role in C. elegans innate immunity
as was shown by three pivotal studies.
In the first one, Aballay et al. found
that Salmonella typhimurium coloniza-
tion of the C. elegans intestine leads to an
increased level of cell death in the worm,
dependent on the well-characterized EGL-
1/CED-9/CED-4/CED-3 pathway (Aballay
and Ausubel, 2001). In an ensuing arti-
cle, the same researchers proved that
Salmonella-induced apoptosis requires
the C. elegans homolog of the mam-
malian p38 mitogen-activated protein
kinase (MAPK) encoded by the pmk-1
gene, a well-characterized and conserved
innate immune effector (Aballay et al.,
2003). Inactivation of pmk-1 by RNAi
blocked Salmonella-elicited C. elegans
apoptosis, and epistasis analysis showed
that CED-9 lies downstream of PMK-1
(Aballay et al., 2003). These results suggest
that the apoptosis and immune response
pathways are linked at some point to
ensure the survival of the multicellular
organism. A potential explanation for
this link would be that apoptosis might
be triggered by the host immune sys-
tem to serve a protective role against the
infectious process by eliminating infected
cells thus hindering the dissemination
of the invading pathogen. Interestingly,
a similar relationship between immu-
nity and apoptosis was recently shown in
Drosophila melanogaster flies (Apidianakis
et al., 2009). Specifically, the researchers
investigated a Pseudomonas aeruginosa gut
infection model in flies and found that the
infection activated the c-Jun-N-terminal
Kinase (JNK) pathway which in turn pro-
moted apoptosis of infected enterocytes.
Further, this phenomenon led to a subse-
quent over-proliferation of intestinal stem
cells as a compensatory mechanism, thus
suggesting a close interaction between
immunity and pathways that control cell
fate. In another article, researchers found
that DAPK-1, theC. elegans ortholog of the
tumor suppressor death-associated pro-
tein kinase, which is a known regulator of
apoptosis and autophagy, decreases innate
immune responses to barrier damage, thus
protecting the worms from inflammation
due to uncontrolled over activation of
their immune system (Tong et al., 2009).
This finding reveals a unique interplay
between apoptosis, inflammation and can-
cer, suggesting that, throughout evolution,
programmed cell death has acquired the
role of protecting the organism from a
wide variety of environmental insults.
APOPTOSIS AND DNA DAMAGE
RESPONSES
The apoptotic pathway is directly linked
to DNA damage control. To prevent
growth of transformed cells, cell-cycle
control proteins inhibit mitotic progres-
sion and promote apoptosis in response to
DNA damage signals. These proteins are
known as tumor suppression proteins and
perhaps the most widely acknowledged
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among them is p53. Indeed, mutations in
p53 have been found invariably in almost
all different types of human cancer (Goh
et al., 2011). The only p53-like protein
in C. elegans is encoded by cep-1 that
is required for DNA-damage and UV-
induced apoptosis. In the nematode, p53
is activated in response to DNA damage
response signals and it induces egl-1 and
ced-13 that encodes another BH3 only pro-
tein that serves in parallel to EGL-1 to
promote apoptotic pathway initiation in
such cases (Bailly and Gartner, 2013).
Interestingly, p53 is highly regulated
in all organisms. In C. elegans, the main
regulatory protein of p53 seems to be
ATR, a serine/threonine protein kinase
that recognizes single-stranded DNA gen-
erated by the recession of double-strand
DNA breaks (Bailly and Gartner, 2013).
However, recent studies have shown that
there are other proteins that can regu-
late p53 either in parallel or together with
ATR. For example, deletion of the gene
encoding histone demethylase JMJD2, the
human homologs of which are amplified
in cases of cancer, slows DNA replication,
blocks progression to S phase, and pro-
motes ATR/p53-dependent apoptosis in
the nematodes (Black et al., 2010). Further,
a pivotal article elucidated the connec-
tion between Hypoxia-Inducible Factor 1
(HIF-1), a protein that is found to be
upregulated in solid tumors and is associ-
ated with cancer prognosis, and apoptosis.
The researchers used C. elegans to show
that HIF-1 upregulates TYR-2, a member
of the tyrosinase family in sensory neu-
rons, which is then secreted and acts on
the germline to antagonize cep-1 depen-
dent apoptosis (Sendoel et al., 2010). This
observation not only identifies a potential
adjunctive therapeutic target for tumors
carrying the increased hif-1 phenotype,
but also shows that inhibition of apoptosis
can sometimes be a non-autonomous cell
response in multicellular organisms.
Importantly, an interesting inter-
play between pathways that are related
to aging, cancer, and apoptosis was
suggested by Perrin et al. (2013). The
researchers investigated the interac-
tions between DAF-2 (an insulin/IGF-1
homolog associated with aging), CEP-
1, and AKT-1 (a protein that belongs
to the Protein Kinase B/AKT family of
protein kinases that are implicated in
a wide range of human cancers). While
AKT-1 inhibits CEP-1 and thus decreases
DNA damage-induced apoptosis, DAF-2
antagonizes these effects and promotes
apoptosis by parallel pathways through
inhibition of AKT-2 and activation of
Ras signaling. Therefore, the insulin/IGF
receptors could serve as potential targets
in AKT-dependent cancers.
Finally, other significant and recently
identified effectors of the DNA damage
response mechanism are the microRNAs
(miRNAs), which have been shown to have
an altered expression in tumor tissues and
are implicated in the regulation of cel-
lular response to radiation-induced DNA
damage. Importantly, in a recent article,
researchers investigated the role of miR-34,
a conserved type of miRNA, on C. elegans
and found that miR-34 has a differen-
tial effect in apoptotic vs. non-apoptotic
cell death after radiation. In fact, miR-
34 was shown to protect cells from non-
apoptotic death while serving a role in
promoting apoptosis (Kato et al., 2009).
The significance of this finding becomes
evident when one considers that the main
response to radiation in some types of
cancer is non-apoptotic death. Therefore,
compounds that are able to lower miR-34
levels in these malignant cells could serve
as important adjuncts to radiotherapy.
APOPTOTIC CORPSE CLEARANCE
The final piece of the apoptotic machin-
ery is the engulfment and degradation
of the apoptotic corpse which is induced
by certain signals expressed on the mem-
brane of the dying cells. Notably, the
most well-recognized of these signals,
a protein known as phosphatidylserine,
has been proven to serve a substan-
tial role in protecting mammalian organ-
isms from lung inflammatory disorders
(Savill et al., 2003), thus establishing the
role of this pathway as a method to
prevent inappropriate immune activation
due to accumulating dead cell remnants.
In C. elegans, the engulfment is medi-
ated by two pathways that include multi-
ple proteins like CED-1, CED-2, CED-5,
CED-6, CED-7, CED-12, and both con-
verge at CED-10 (a Rac family GTPase)
(Kinchen et al., 2005), while the degrada-
tion is mediated by signals involving the
RAB-5 protein and ending with lysoso-
mal degradation of the corpse (Conradt
and Xue, 2005). Contributing to the
well-appreciated notion that disturbance
of the corpse degradation pathway can
be related to various autoimmune dis-
orders (Nagata et al., 2010), Haskin
et al. described a molecular link between
CED-1 and innate immunity in C. ele-
gans (Haskins et al., 2008). They found
that in C. elegans, CED-1 upregulates a
family of genes encoding proteins with
prion-like glutamine/asparagine (Q/N)-
rich domains, known to be activated by ER
stress and thought to aid in the unfolded
protein response (Urano et al., 2002), thus
rendering ced-1 mutant worms immuno-
compromised and very susceptible to
Salmonella enterica infection. These find-
ings indicate that ced-1 is required for the
transcriptional activation of an unfolded
protein response pathway essential for
proper response to invading pathogens
(Lamitina and Cherry, 2008). Despite the
fact that the investigators suggested that
the function of CED-1 in innate immu-
nity is not dependent upon its function in
apoptotic corpse engulfment, the impor-
tance of this observation cannot be over-
looked as it implies that at least some of
the effectors of the engulfment pathway
can in fact have multiple roles, functioning
to protect the organism against noxious
stimuli resulting either fromwithin the cell
(in case of abnormally folded proteins) or
from its surrounding environment (in the
case of apoptotic corpse clearance).
On the other hand, the interaction
between dying cell removal and cancer is
less clear. In a recent article, researchers
showed that sli-1, the homolog of the
mammalian proto-oncogene c-Cbl, is able
to inhibit engulfment of the dying cells
through a previously unidentified pathway
(Anderson et al., 2012). More importantly
though, in another study, Suzuki et al.
showed that XK-family proteins promote
phosphatidylserine exposure on the mem-
brane of dying cells in response to apop-
totic signals and found that XK-Related
Protein 8, a member of the XK family, is
epigenetically repressed in some types of
human cancer cells (Suzuki et al., 2013).
Both of these findings suggest a mechanis-
tic association between autoimmunity and
cancer in which apoptotic corpse degrada-
tion seems to have a central role.
CONCLUSIONS
It is evident that research based on C. ele-
gans has provided us with a wide variety
of previously unrecognized interactions
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FIGURE 1 | Apoptosis signaling pathways in C. elegans during development (Purple),
stress/infection (Gray), and hyperproliferation (Pink). Lines with arrowheads represent
activation while lines with barheads represent deactivation. Mammalian homologs are shown in
brackets when applicable.
between programmed cell death and path-
ways that contribute to immunity or lead
to cancer (Figure 1). It is now widely
accepted that the apoptotic machinery
serves a much wider role in multicellu-
lar organisms than what was previously
acknowledged. It seems that this pathway
is necessary tomaintain tissue homeostasis
not only under normal development but
especially under conditions that are asso-
ciated with cellular stress. In fact, apop-
tosis should be considered as the last
physiologic safeguard in response to envi-
ronmental insults. When all other repair
mechanisms fail, programmed cell death
is activated as a failsafe mechanism to
sacrifice the affected cells for the greater
good of the organism. Keeping this sim-
ple principle in mind, it is easy to deduce
the interactions between apoptosis, cancer,
and immunity. More specifically, infec-
tious processes are well-recognized envi-
ronmental insults, therefore programmed
cell death can aid in preventing the dis-
semination of the pathogen especially
when it comes to intracellular microbes.
Similarly, in the case of cancer-inducing
insults, like ionizing radiation, the apop-
totic machinery is triggered in an effort
to kill the malignant cells and protect
the host from their uncontrolled prolif-
eration that could be detrimental to its
well-being. On the other hand, uncon-
trolled activation of programmed cell
death can negatively impact the organ-
ism. Therefore, finding a way to specif-
ically induce the apoptotic pathway in
the affected cells could provide us with
a powerful weapon in our fight against
human diseases, like cancer and infectious
processes.
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